Objective: To evaluate the safety and efficacy of diagnosis and treatment of pleuroperitoneal communication in patients on peritoneal dialysis by computerized tomography (CT) peritoneography and thoracoscopic surgery. Methods: The records of 8 pleuroperitoneal communication patients treated by thoracoscopic surgery in Peking University First Hospital from January 2012 to March 2017 were retrospectively reviewed.CT peritoneography was performed before surgical treatment. Iopamiro (50 ml∶15 g) was mixed with 2 L of peritoneal dialysate solution, and then was instilled into the peritoneal cavity through the Tenckhoff catheter. After dwelling for 1 hour, CT scan was taken from thorax to upper abdomen.The thoracic cavity was filled with sterile saline, and then carbon dioxide was inflated to the peritoneal cavity via Tenckhoff catheter.Air bubbles leaking from the diaphragmatic defect were identified during thoracoscopic operation.Then defect was repaired and pleurodesis was performed. Results: The CT value of pleural effusion increased to (155±57) HU.Pleuroperitoneal communication was clearly diagnosed.The diaphragmatic defects in 5 cases were detected and repaired.However, defects in the other 3 cases were not found.The mean operative time was (152±50) minutes. All patients had uneventful recovery and reinstated normal peritoneal dialysis 3 weeks after the operation.The median follow-up time was 14.5 months (1-68 months) and no recurrence occurred. Conclusions: CT peritoneography could identify pleuroperitoneal communication clearly. Thoracoscopic surgery is a safe and reliable method for pleuroperitoneal communication and could restore patients to peritoneal dialysis.
目的: 评估在腹膜透析(腹透)并发胸腹瘘的患者中CT腹膜造影诊断和胸腔镜手术治疗的安全性和有效性。 方法: 回顾分析2012年1月至2017年3月北京大学第一医院通过胸腔镜手术治疗8例腹透并发胸腹瘘患者的临床资料。术前行CT腹膜造影,将对比剂碘海醇(50 ml∶15 g)混合在2 L腹透液,然后将稀释的对比剂经腹透管注入腹腔,1 h后行胸部及上腹部CT扫描。胸腔镜手术中将无菌生理盐水注入胸腔,通过腹透管把二氧化碳气体注入腹腔,通过逸出气泡的位置对膈肌缺损进行定位并修补,最后行胸膜固定术。 结果: 胸腔积液的CT值增强至(155±57) HU,胸腹瘘可确诊。5例术中可见明确的膈肌缺损予直接缝合,另外3例未能寻到膈肌缺损处。手术时间为(152±50) min。所有患者无围手术期并发症,在术后3周开始恢复正常腹透。术后中位随访时间为14.5个月(1~68个月),随访无复发。 结论: 对于腹透合并胸腹瘘的患者,CT腹膜造影可明确胸腹瘘的存在。胸腔镜手术治疗安全可靠,可使患者恢复腹透治疗。.
Keywords: Hydrothorax; Peritoneal dialysis; Peritoneography; Pleuroperitoneal communication; Thoracoscopy.